Angell M (2004) Over and above: Excess in the pharmaceutical industry. CMAJ 171: 1451.
[2]
Young JH (1961) The toadstool millionaires: A social history of patent medicines in America before federal regulation. Princeton (New Jersey): Princeton University Press. 282 p.
[3]
Lears J (1994) Fables of abundance: A cultural history of advertising in America. New York: Basic Books. 512 p.
[4]
Laird PW (1998) Advertising progress: American business and the rise of consumer marketing. Baltimore (Maryland): Johns Hopkins University Press. 480 p.
[5]
Sahlins M (1994) Culture/power/history: Reader in contemporary social theory. In: Eley G, Dirks NB, Ortner SB, editors. Cosmologies of capitalism: The trans-pacific sector of “The World System”. Princeton (New Jersey): Princeton University Press. pp. 412–456.
[6]
Sahlins M (1996) The sadness of sweetness: The native anthropology of Western cosmology. Curr Anthropol 37: 395–428.
[7]
Lexchin J (2006) Bigger and better: How Pfizer redefined erectile dysfunction. PLoS Med 3: e132. doi: 10.1371/journal.pmed.0030132.
[8]
Tiefer L (2006) Female sexual dysfunction: A case study of disease mongering and activist resistance. PLoS Med 3: e178. doi: 10.1371/journal.pmed.0030178.
[9]
Levitt T (1986) The marketing imagination. New York: Free Press. 238 p.
[10]
Harmon A2005 Young, assured and playing pharmacist to friends. New York Times. 1116 Available: http://www.nytimes.com/2005/11/16/health？/16patient.html?ex=1289797200&en=ecbeab2？5b58126c4&ei=5088&partner=rssnyt&emc=rss. Accessed 6 March 2006 .
